Appendix C
Vaccinations and immunisations
Uptake of the 6-in-1 vaccine
The 6-in-1 vaccine is a combined DTaP IPV Hib HepB vaccine. It is the first in a course of vaccines offered to babies to protect them against diphtheria, pertussis (whooping cough), tetanus, Haemophilus influenzae type b (an important cause of childhood meningitis and pneumonia), polio (IPV is inactivated polio vaccine) and Hepatitis B.
6-in-1 at 12 months
The percentage of 1-year-olds in Bromley who have received the 6-in-1 vaccine has been consistently above 90%. There has been a general downward trend in update during that. There was a further small decrease last year where the percentage fell from 92.1% in 2023/24 to 91.2% in 2024/25. Whilst this is still above the London average of 86.3%, it is below the national average of 91.3%.
Uptake of MMR vaccinations
MMR is the combined vaccine that protects against measles, mumps and rubella. The first MMR vaccine is given to children as part of the routine vaccination schedule, usually within a month of their first birthday. They’ll then have a booster dose before starting school, which is usually between three and five years of age.
MMR 2-year-olds
The percentage of 2-year-olds in Bromley who have received the MMR vaccine has been consistently around 90% during the past decade. There was a small decrease last year where the percentage fell from 90.0% in 2023/24 to 88.2% in 2024/25. Whilst this is still above the London average of 80.8%, it is below the national average of 88.9%.
MMR 5-year-olds (one dose)
Whilst the percentage of 5-year-olds in Bromley who have received a single dose of the MMR vaccine has been consistently above 90% during the past decade, there has been downward trend in uptake during that time. There was a further decrease last year where the percentage fell from 91.3% in 2023/24 to 90.5% in 2024/25. Whilst this is still above the London average of 84.4%, it is below the national average of 91.8%.
MMR 5-year-olds (two doses)
The percentage of 5-year-olds in Bromley who have received two doses of the MMR vaccine has been consistently between 86-90% during the past decade, there has been downward trend in uptake since 2018/19. There was a large decrease last year where the percentage fell from 86.1% in 2023/24 to 77.7% in 2024/25. Whilst this is still above the London average of 69.6%, it is below the national average of 83.7%.